Y.S.P. Industries (M) Sdn Bhd,a wholly owned subsidiary of Y.S.P.SAH established since 1987 with a PIC/s GMP manufacturing plant in Bangi, Malaysia. The company is involving principally the manufacturing, marketing and distribution of a wide range of generic products that include Tablet, Capsule, Eye-drops, Small Volume Injection, Syrup/Suspension, Cream/Ointment and Suppository. Our products range from a broad array of Pharmaceutical, Over the Counter (OTC), Traditional Complimentary Medicine (TCM), Cosmeceutical to Animal Health products. As corporate headquarter located in Malaysia, Y.S.P.SAH has aggressively involved in export business through our affiliates abroad, from Asia to Middle East and Africa region.
Yamasa Biochemicals Division has advanced research for the next generation in nucleic acid related compounds which are now used in broad fields such as APIs, and pharmaceutical intermediates. Along with our abundant experience and technology accumulated for many years, Yamasa provides products and contract services which realize your various needs.
We are professional chemical manufacturer with over 20 year's experience in producing Chloride compounds and Bromide compounds. We have ISO Certification for quality and environment. Being the supplier of many big pharmaceutical factories we pursue the service principal of high quality, reasonable price, adequate inventory, and good faith cooperation.
Yancheng Ming Yuan Pharmaceutical Co Ltd is a sales trading enterprise engaged in the veterinary pharmacation raw materials, the domestic veterinary drugs bulk drugs GPS certification through the enterprise.
Strong partnership with the major pharmaceutical, veterinary raw materials producers, agents, operating varieties covering therapeutic class, more than 400 varieties of prevention class, insecticide classes, nutrition and feed additives such as major categories of raw materials (specifications).
Yangtze River Pharmaceutical Group (hereinafter refers to YRPG) is a large-scale cross-region pharmaceutical group which is one of the key enterprises in China. Founded in 1971, YRPG has been in Top 3 for comprehensive economic benefit in national pharmaceutical industry for over ten years since 1997. In 2010, the total sales revenue reached RMB 25 billion. At present, YRPG has over 8000 employees, with total assets of over RMB 9 billion and a total floor area of over 2 million square meters. With Yangtze River Pharmaceutical Co Ltd as the core entity, the group owns 7 subsidiaries in Beijing, Shanghai, Nanjing, Guangzhou etc. and has established R&D and production bases of innovative chemical medicine, patent traditional Chinese medicine (TCM) and biological medicine. YRPG is able to support a product line with diversities and sound development, and has established a product structure of 10 series, covering over 10 dosage forms and around 150 products, including both Western and Traditional Chinese Medicines and in which over 20 have reached USP, BP and EP standards.
Yangzhou Liberty Pharmaceutical Co Ltd is an API manufacturer, and a joint venture whose main body is Yangzhou Pharmaceutical Co Ltd, located in Yangzhou. In 2013, our company became the holding company of Datong Tongxing Antibiotic Co Ltd in Shanxi Province. We will also develop and produce other fermentation raw materials. With advanced quality management system, we have some products which passed the US FDA inspection and also gained COS, EU-GMP and GMP certificates.,Yangzhou Liberty Pharmaceutical Co Ltd, Anhui Liberty Pharmaceutical Co Ltd and Datong Tongxing Antibiotic Co Ltd, as your reliable partners, are determined to provide excellent products and service to friends from all over the world.
Yangzhou Pharmaceutical Co Ltd, originally Yangzhou Pharmaceutical Factory, was founded in 1958, and mainly manufactures steroid hormones, antibiotics, antihistamines, and cardiovascular products. It provides APIs and intermediates. As of June 7, 2013, Yangzhou Pharmaceutical Co., Ltd. operates as a subsidiary of Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Yantai Dongcheng Biochemicals, is one of the largest biochemical API manufacturers in China. The company's products have been exported to more than fifty countries. Main products including Heparin Sodium, Chondroitin sulphate, Cytochrome C, Hyaluronic Acid, Collagen, and Glucosamine etc are in compliance with the EP, JP and USP. For Heparin Sodium, we have passed U.S. FDA site audit, German Hamburg GMP certificate, European CEP certificate. For Chondroitin sulphate, we have achieved FDA DMF registration number and European CEP certificate. Furthermore, YanTai DongCheng has passed SFDA GMP audit, and achieved DNV ISO9001 International Quality System certification.
We are a professional manufacturer and supplier of pharmaceutical machinery. Our main products include wet granulator, fluid bed dryer, bin blender, coating machine, lifter and washing station. We provide first-class GMP, CGMP, FDA, CE, TUV, ISO9001:2008 standard machinery and total pharmaceutical solution & complete set of equipment. All products are widely used in Pharmaceutical, Chemical, Foodstuff industry.
Yingkou Sanzheng New Technology Chemical Industry Co Ltd specializes in pharmaceutical intermediates, fine chemicals & custom synthesis. The company has rich resource of CNCl, HCN and H2 and has been developing products based on these raw materials. We are also your right partner for custom production. Our leading products are:- Chlorosulfonyl Isocyanate, Sodium Dicyanamide, Sodium Cyanoborohydride, 1,3 -Diaminoguanidine HCl, 3-Butyu-1-0l, and 9-azabicyclo[3.3.1]nonan-3-one.Looking forward to good cooperation with you!
Yino Pharma Limited is fully integrated EU-GMP certified producer of Heparin range Anticoagulants: Heparin Sodium (EU-GMP), Heparin Calcium (EU-GMP applied), Dermatan Sulfate, Heparinoid Sodium, Mucopolysaccharide Polysulfate, Enoxaparin Sodium (EU-GMP applied). Further Heparin derivatives under development.
Best possible implementation of Annex 2 to EU-GMP Guidelines and FDA Guidance for Industry: From intestine to API - all at one site.
Additional facility for biological active substances: Bile Derivatives, Black Currant Extract, Chondroitin Sulfate Sodium, Chondroitin Sulfate Calcium, Liver Extract, Pancreatin (EU-GMP applied), Lung Surfactant.
YONSUNG's highest priority is the top quality of APIs. We manufacture APIs in accordance with ICH Guidelines (Q7) and export to the US, EU, Japan and other countries. YONSUNG continuously monitors new requirements from the FDA, ICH, EMEA and WHO. YONSUNG is fully approved by USFDA, European and Japanese authorities for the development and manufacture of APIs.
YooYoung Pharmaceutical Co., Ltd. places a high value on improving the health of human being and we have achieved sustainable growth and development since its foundation, 1981 and we are dedicated to aim to be the highest level of pharmaceutical manufacturer through the realization of long-term planning.
Ypsomed is the leading independent developer and manufacturer of innovative and user-friendly self-injection systems. The customisable product platforms cover autoinjectors for prefilled syringes in 1 mL and 2.25 mL formats, prefilled patch injectors, disposable pens for 3 mL and 1.5 mL cartridges, re-usable pens that include automated injection mechanisms and easy-to-use injection devices for drugs in dual-chamber cartridges. Unique click-on pen needles and infusion sets complement the broad self-injection systems product portfolio. Ypsomed provides its partners with a complete range of technical expertise and full regulatory support for the device relevant aspects of the registration process.
Yueyang Xiangmao Medicines & Chemicals Co., Ltd. is the enterprise which dedicates to specialization production of Methyl Sulfonyl Methane and faces global market. At present, we can produce methyl sulfone with many specifications and many applications. Product specification include 5-20 mesh, 20~40mesh, 40~60mesh, 60-80mesh, 80-100 mesh and others. We can still produce methyl sulfone with special specification.
Since its foundation more than 70 years ago, Yuki Gosei Kogyo Co., Ltd. has used its unique and proprietary technologies to research, develop, and manufacture a variety of fine chemical products beneficial for human life and health.
We will continue to expand our existing lines while developing new business frontiers based on fine chemicals where Yuki Gosei's long expertise can be best applied. The development of active pharmaceutical ingredients and high value intermediates is our highest priority. We are also focusing on the new applications for our existing products such as Glycine, pyridine and piperidine compounds as well as silicon-based compounds,
YungShin started its business in 1952 and since 1978 YungShin has also established affiliates worldwide including Yung Zip Chemical in Taiwan, CTI in the US, YSP Southeast Asia and YSP China. YungShin specializes in the development and production for finished products and APIs. YungShin is also strict in adherence to the most sophisticated ERP system, SAP, SOPs and diligent compliance to PIC/S GMP, Japanese MHLW and US FDA regulations. YungShin provides integrated drug development and contract manufacturing services from Taiwan facilities.
Since its establishment in 1952, Yungjin Pharm. Co., Ltd. has been enjoying the privilege of playing a major role as a forerunner in the Korean pharmaceutical industry for over half a century. Based on our long-term goal, we strive for further growth and expansion. Strong alliance with the worldwide pharmaceutical companies allows us to expand our market into the worldwide and cope with the challenging environment of global pharmaceutical industry. Through active involvement in R&D activities, quality management and overseas business, we will fulfill the expectations of our customers and shareholders.